Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
Settings
KERX [NASD]
Keryx Biopharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.22 Insider Own1.10% Shs Outstand103.60M Perf Week-0.35%
Market Cap1.18B Forward P/E- EPS next Y-0.25 Insider Trans-34.10% Shs Float101.72M Perf Month-13.95%
Income-111.50M PEG- EPS next Q-0.30 Inst Own75.70% Short Float30.12% Perf Quarter-13.76%
Sales10.80M P/S109.45 EPS this Y-112.10% Inst Trans0.50% Short Ratio19.08 Perf Half Y-28.73%
Book/sh0.80 P/B14.26 EPS next Y73.70% ROA-83.60% Target Price23.55 Perf Year-18.67%
Cash/sh0.83 P/C13.78 EPS next 5Y- ROE-101.30% 52W Range10.85 - 18.48 Perf YTD-19.36%
Dividend- P/FCF- EPS past 5Y-51.00% ROI-152.40% 52W High-38.26% Beta3.14
Dividend %- Quick Ratio3.10 Sales past 5Y-15.60% Gross Margin95.40% 52W Low5.16% ATR0.49
Employees155 Current Ratio3.40 Sales Q/Q- Oper. Margin- RSI (14)38.54 Volatility3.78% 3.81%
OptionableYes Debt/Eq0.00 EPS Q/Q-109.50% Profit Margin- Rel Volume0.91 Prev Close11.73
ShortableYes LT Debt/Eq0.00 EarningsMay 07 BMO Payout- Avg Volume1.61M Price11.41
Recom1.80 SMA20-6.51% SMA50-8.81% SMA200-20.48% Volume1,468,828 Change-2.73%
Apr-20-15Reiterated Stifel Buy $19 → $17
Mar-20-15Reiterated Oppenheimer Outperform $22 → $18
Mar-02-15Reiterated Stifel Buy $22 → $19
Feb-27-15Reiterated ROTH Capital Buy $32 → $27
Feb-03-15Reiterated Mizuho Buy $30 → $25
Dec-02-14Reiterated FBR Capital Underperform
Nov-28-14Reiterated Maxim Group Buy $26 → $32
Nov-17-14Reiterated FBR Capital Underperform $14 → $12
Sep-22-14Resumed Oppenheimer Outperform $22
Sep-08-14Downgrade FBR Capital Mkt Perform → Underperform
Aug-14-14Initiated FBR Capital Mkt Perform $16
May-23-14Reiterated H.C. Wainwright Buy $19
May-12-14Reiterated MLV & Co Buy $27 → $21
Apr-04-14Reiterated Ladenburg Thalmann Buy $24 → $30
Apr-02-14Reiterated Mizuho Buy $25 → $34
Apr-01-14Reiterated Oppenheimer Outperform $20 → $22
Mar-21-14Initiated Mizuho Buy $25
Mar-14-14Reiterated Stifel Buy $17 → $19
Jan-27-14Reiterated Maxim Group Buy $16 → $25
Oct-17-13Reiterated Ladenburg Thalmann Buy $15 → $19
Apr-24-15 04:32PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
Apr-23-15 08:29AM  Keryx Biopharmaceuticals Appoints John F. Neylan, MD, as Chief Medical Officer at noodls
08:00AM  Keryx Biopharmaceuticals Appoints John F. Neylan, MD, as Chief Medical Officer GlobeNewswire
Apr-09-15 07:56AM  Keryx Biopharmaceuticals Live on Revenue Management Cloud Using Model N Express at noodls
Mar-26-15 07:33PM  Lightning Round: This was a 'one and done' at CNBC
Mar-18-15 04:15PM  Dyadic International Announces The Appointment Of Jack Kaye To Its Board of Directors PR Newswire
Mar-17-15 09:23AM  Analyzing The Baupost Groups Holdings in 4Q14
Mar-15-15 09:09AM  Billionaire Seth Klarmans Biotech Stock Picks at Insider Monkey
Mar-10-15 05:37PM  Keryx Biopharmaceuticals Announces Appointment of Greg Madison to Its Board of Directors at noodls
05:01PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
04:55PM  Keryx Biopharmaceuticals Announces Appointment of Greg Madison to Its Board of Directors GlobeNewswire
Mar-07-15 01:04PM  KERYX BIOPHARMACEUTICALS INC Financials
Mar-04-15 08:05AM  Keryx Biopharmaceuticals Announces Publication of Auryxia(TM) (ferric citrate) Analysis in Journal of the American Society of Nephrology at noodls
08:05AM  Keryx Announces Fourth Quarter and Year-End 2014 Financial Results at noodls
07:45AM  Keryx Biopharmaceuticals Announces Publication of Auryxia(TM) (ferric citrate) Analysis in Journal of the American Society of Nephrology GlobeNewswire
Mar-02-15 12:10PM  Keryx Biopharmaceuticals' Q4 Loss Wider than Expected - Analyst Blog
09:43AM  Keryx Spotlights Biotech Challenge at The Wall Street Journal
12:28AM  Overheard: Keryxs Value in Profits at The Wall Street Journal
Mar-01-15 03:39PM  Overheard: Keryx's Value in Profits at The Wall Street Journal
Feb-27-15 08:31AM  Keryx's (KERX) Q4 Loss Misses Expectation, Auryxia in Focus - Tale of the Tape Zacks
08:00AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today CCBN
07:46AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations an EDGAR Online
07:15AM  Keryx Biopharma reports 4Q loss AP
07:07AM  Q4 2014 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open CCBN
07:00AM  Keryx Announces Fourth Quarter and Year-End 2014 Financial Results GlobeNewswire
Feb-26-15 10:50AM  What Awaits Keryx Biopharmaceuticals (KERX) this Earnings? - Analyst Blog Zacks
Feb-25-15 04:10PM  Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences GlobeNewswire
Feb-18-15 08:00AM  Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2014 Financial Results GlobeNewswire
Feb-09-15 08:36AM  Well-Fed Analysts Stay Mum on Keryx Biopharma's Slow Drug Launch at TheStreet
Jan-27-15 04:35PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Jan-22-15 04:10PM  Keryx to Raise $110 Million Through Issuance of Shares - Analyst Blog Zacks
08:31AM  Keryx Biopharmaceuticals (KERX) in Focus: Stock Falls by 6.8% - Tale of the Tape Zacks
Jan-21-15 07:53PM  Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock GlobeNewswire -6.81%
01:38PM  4 More Biotech Secondaries Traders Are Watching Benzinga
08:55AM  Wednesday Morning Movers: Netflix Flying High Benzinga
Jan-20-15 04:05PM  Keryx Biopharmaceuticals, Inc. Announces $100 Million Proposed Public Offering of Common Stock GlobeNewswire
Jan-12-15 08:40AM  Dyadic Appoints Michael Tarnok As Chairman Of The Board Of Directors PR Newswire
07:19AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and EDGAR Online
01:04AM  Big deals, data kick off JPMorgan health conference at CNBC
Jan-11-15 10:00PM  Keryx Biopharmaceuticals Announces Transition of Leadership GlobeNewswire
Jan-08-15 07:46AM  Keryx Biopharmaceuticals Shares May Hit $25 at Barrons.com +5.04%
Jan-07-15 09:19AM  UPDATE: MLV & Co Raises PT On Keryx Biopharmaceuticals On Additional Auryxia Growth Potential Benzinga
07:30AM  Keryx Biopharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-30-14 01:50PM  Keryx drug for dialysis patients poised to challenge Genzyme at American City Business Journals
Dec-22-14 07:30AM  Keryx Biopharmaceuticals Announces Commercial Launch of AURYXIA(TM) (ferric citrate) Tablets in the United States GlobeNewswire
07:30AM  Keryx Biopharmaceuticals Announces Commercial Launch of AURYXIA (ferric citrate) Tablets in the United States PR Newswire
Dec-17-14 08:30AM  TG Therapeutics, Inc. Announces Appointment of Kenneth Hoberman to Board of Directors GlobeNewswire
Dec-11-14 05:02PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Dec-08-14 07:30AM  Keryx Biopharmaceuticals, Inc. to Present at the Oppenheimer & Co. Inc. 25th Annual Healthcare Conference GlobeNewswire
Dec-05-14 12:00PM  Baupost adds to position in Keryx Biopharmaceuticals Market Realist +5.07%
Dec-04-14 07:30AM  Keryx Biopharmaceuticals Announces Issuance of a New U.S. Patent for Auryxia(TM) (ferric citrate) Covering Orally Administrable Forms GlobeNewswire
Dec-02-14 07:30AM  Auryxia(TM) (Ferric Citrate) Phase 2 Data Published in the American Journal of Kidney Disease GlobeNewswire
Dec-01-14 10:00AM  Keryx Biopharmaceuticals (KERX) Highlighted As Weak On High Volume at TheStreet
Nov-18-14 01:17PM  Mid-Day Market Update: SunEdison, TerraForm Jump On First Wind Acquisition; TJX Shares Drop Benzinga
06:03AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Nov-17-14 05:15PM  Keryx Biopharmaceuticals Announces Trade Name Auryxia(TM) for Ferric Citrate GlobeNewswire
04:56PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Nov-15-14 10:00AM  Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase 3 Long-Term Safety Extension Study GlobeNewswire
Nov-14-14 06:08PM  Baupost's Seth Klarman Buys Cheniere Energy, Ocwen Financial, Antero Resources, Sells Boyd ... Gurufocus
08:30AM  Keryx Biopharmaceuticals, Inc. to Present at the Stifel 2014 Healthcare Conference GlobeNewswire
Nov-12-14 12:33PM  A quarterback's market playbook CNBC
Nov-10-14 07:09PM  Lighting Round: This one is a strong buy at CNBC
07:07PM  Cramer Remix: Stocks with years of upside at CNBC
Nov-08-14 07:07PM  10-Q for Keryx Biopharmaceuticals, Inc. Company Spotlight
Nov-07-14 09:52AM  Keryx Biopharmaceuticals (KERX) Highlighted As Today's Perilous Reversal Stock at TheStreet
06:24AM  Keryx (KERX) in Focus: Stock Adds 11.9% in Session Zacks
Nov-06-14 08:00AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today CCBN +11.91%
07:36AM  Keryx Biopharma misses Street 3Q forecasts AP
07:31AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
07:07AM  Q3 2014 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open CCBN
07:00AM  Keryx Biopharmaceuticals, Inc. Announces Third Quarter and Nine Month 2014 Financial Results GlobeNewswire
Nov-04-14 03:35PM  Will Keryx Biopharmaceuticals (KERX) Post Wider Q3 Loss? Zacks
Oct-30-14 08:00AM  Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2014 Financial Results GlobeNewswire
Oct-28-14 01:12PM  Big Board Biotech Stocks in Play This Week Accesswire
Oct-23-14 10:52AM  Keryx Biopharmaceuticals Announces Ferric Citrate Presentations at the Upcoming American Society of Nephrology Kidney Week 2014 Annual Meeting GlobeNewswire
Oct-10-14 07:00AM  Biotech Stock Mailbag: Keryx, Puma, Gilead, Arrowhead and Hate Mail Galore! at TheStreet -5.31%
Oct-08-14 10:22AM  Insider Trading Alert - VNTV, ENTG And KERX Traded By Insiders at TheStreet +5.17%
Oct-01-14 07:30AM  Keryx Biopharmaceuticals Announces Issuance of a New U.S. Patent for Ferric Citrate Covering Orally Administrable Forms GlobeNewswire
Sep-29-14 07:30AM  Keryx Biopharmaceuticals Initiates Pivotal Phase 3 Study of Ferric Citrate for the Treatment of Iron Deficiency Anemia in Patients With Non-Dialysis Dependent Chronic Kidney Disease GlobeNewswire
Sep-11-14 10:30AM  Insider Trading Alert - DVA, DATA And KERX Traded By Insiders at TheStreet
07:59AM  The Zacks Analyst Blog Highlights: AbbVie, Infinity Pharmaceuticals, Keryx Biopharmaceuticals, Gilead and Amgen Zacks
Sep-08-14 05:05PM  Keryx Falls after Ferric Citrate's Approval with Warnings Zacks -11.17%
04:09PM  Keryx CEO says FDA warning label for drug is 'grossly misunderstood' at MarketWatch
01:11PM  [$$] Keryx's FDA Approval a Mixed Bag at Barrons.com
11:25AM  Why Keryx Biopharmaceuticals (KERX) Stock Is Falling Today at TheStreet
07:09AM  Keryx Biopharmaceuticals (KERX) Crumbles: Stock Falls by 5.5% Zacks
07:00AM  Keryx Bear Case Bolstered by Less-Than-Zippy 'Zerenex' Label at TheStreet
06:20AM  Keryx Biopharma downgraded by FBR Capital Briefing.com
Sep-06-14 09:01AM  Correction: Keryx-Drug Approval story AP
Sep-05-14 08:59PM  Warnings Issued for Keryx Dialysis Drug at New York Times -5.45%
05:08PM  FDA approves Keryx's kidney drug with warnings, shares fall Reuters
05:03PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:00PM  Keryx Biopharmaceuticals, Inc. to Present at the Rodman & Renshaw 16th Annual Global Investment Conference GlobeNewswire
03:05PM  Keryx Finds Out That Not All FDA Approvals Are Great Wins at 24/7 Wall St.
02:49PM  Infoblox Inc. (BLOX) Climbs On Earnings at TheStreet
12:36PM  Infoblox Inc Gains On Upbeat Results; The Gap Inc. Shares Decline Benzinga
12:00PM  Keryx Biopharmaceuticals Inc Conference Call to discuss the approval of Ferric Citrate scheduled for 12:00 pm ET today CCBN
11:28AM  Keryx Biopharma gets U.S. approval for kidney drug Reuters
11:17AM  Keryx Biopharmaceuticals Receives FDA Approval of Ferric Citrate, a New, Oral Iron-Based Treatment for Dialysis Patients With Hyperphosphatemia GlobeNewswire
Aug-26-14 09:50AM  Your September Biotech Back-to-School Calendar at TheStreet
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, as well as treats iron deficiency anemia. Auryxia is also used to control serum phosphorus levels in patients with chronic kidney disease on dialysis. The company also has sublicense agreements with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Auryxia in Japan. It also has strategic alliance with Panion & BF Biotech, Inc. Keryx Biopharmaceuticals, Inc. was founded in 1997 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adams BrianVP and General CounselApr 15Sale12.404,32053,56859,555Apr 17 07:00 PM
BENTSUR RONChief Executive OfficerApr 06Sale11.681,59218,595777,209Apr 08 08:00 PM
Oliviero James F IIIChief Financial OfficerApr 06Sale11.681,87821,935169,738Apr 08 08:01 PM
Madison GregPresident and COOFeb 09Sale10.956,75974,011103,663Feb 10 09:00 PM
BENTSUR RONChief Executive OfficerJan 05Sale13.795,57476,865778,801Jan 06 08:15 PM
Oliviero James F IIIChief Financial OfficerJan 05Sale13.795,60477,279171,616Jan 06 08:13 PM
BENTSUR RONChief Executive OfficerDec 30Sale14.11200,0002,822,000717,000Jan 02 09:30 PM
BENTSUR RONChief Executive OfficerDec 29Sale13.9887,9881,230,072917,000Dec 29 09:40 PM
BENTSUR RONChief Executive OfficerDec 26Sale13.9863,500887,7301,004,988Dec 29 09:40 PM
BENTSUR RONChief Executive OfficerDec 24Sale13.9883,0001,160,3401,068,488Dec 29 09:40 PM
BENTSUR RONChief Executive OfficerDec 23Sale13.98104,4891,460,7561,151,488Dec 29 09:40 PM
Oliviero James F IIIChief Financial OfficerDec 10Option Exercise11.2225,000280,500178,345Dec 12 08:01 PM
Oliviero James F IIIChief Financial OfficerDec 10Sale15.6925,000392,250153,345Dec 12 08:01 PM
BENTSUR RONChief Executive OfficerOct 06Sale15.8768,8001,091,856755,977Oct 07 08:00 PM
Oliviero James F IIIChief Financial OfficerOct 03Sale16.142,69443,481153,345Oct 07 08:00 PM
BENTSUR RONChief Executive OfficerOct 03Sale16.142,03832,893824,777Oct 07 08:00 PM
BENTSUR RONChief Executive OfficerSep 12Sale14.2450,000712,000826,815Sep 12 08:30 PM
Oliviero James F IIIChief Financial OfficerSep 08Sale15.88144,2372,290,484156,039Sep 10 08:00 PM
BENTSUR RONChief Executive OfficerJul 07Sale15.751,78828,161876,815Jul 09 08:00 PM
Oliviero James F IIIChief Financial OfficerJul 07Sale15.752,05432,351300,276Jul 09 08:00 PM